UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-42374 SYNERGY CHC CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organ ...

Financial Performance - Fourth quarter 2024 revenue was $10.3 million, down 22% from $13.2 million in Q4 2023; full year revenue was $34.8 million, down 19% from $42.8 million in 2023[6] - Gross margin for Q4 2024 was 63.3%, compared to 82.3% in Q4 2023; full year gross margin was 67.9%, down from 75.0% in 2023[7] - Net income for Q4 2024 was $105.7 thousand, a decrease from $2.6 million in Q4 2023; full year net income was $2.1 million, down from $6.3 million in 2023[10] - EBITDA for Q4 2024 was $1.7 million, down from $4.5 million in Q4 2023; full year EBITDA was $6.5 million, compared to $10.8 million in 2023[11] - Adjusted EBITDA for Q4 2024 was $2.8 million, up 1,033% from $(0.3) million in Q4 2023; full year Adjusted EBITDA was $7.4 million, an increase of 21% from $6.1 million in 2023[12] - Total revenue for the year ended December 31, 2024, was $34,834,243, a decrease of 18.6% compared to $42,777,633 in 2023[28] - Gross profit for 2024 was $23,643,019, down from $32,080,310 in 2023, reflecting a gross margin decline[28] - Net income after tax for 2024 was $2,124,976, a significant decrease of 66.5% from $6,338,750 in 2023[28] - Comprehensive income for 2024 was $2,179,666, down from $6,213,894 in 2023, reflecting the decline in net income[28] Operating Expenses - Operating expenses in Q4 2024 were $5.1 million, a decrease of 20% from $6.4 million in Q4 2023; full year operating expenses were $17.9 million, down 16% from $21.3 million in 2023[8] - Operating expenses for 2024 were $17,841,771, down from $21,273,564 in 2023, reflecting cost control measures[28] Cash and Liabilities - As of December 31, 2024, Synergy had approximately $687.9 thousand in cash and cash equivalents, an increase from $632.5 thousand as of December 31, 2023[13] - Total liabilities decreased to $33.0 million as of December 31, 2024, down from $39.5 million as of December 31, 2023, reflecting an improvement of $6.6 million[13] - Total current assets increased to $16,059,768 in 2024 from $11,822,849 in 2023, primarily driven by a rise in accounts receivable[26] - Total liabilities decreased to $32,974,444 in 2024 from $39,545,489 in 2023, indicating improved financial leverage[26] - Cash and cash equivalents at the end of 2024 were $687,920, an increase from $632,534 in 2023[26] - The company reported a net cash used in operating activities of $4,803,390 for 2024, compared to a net cash provided of $421,729 in 2023[30] Shareholder Information - The weighted average common shares outstanding increased to 7,588,095 in 2024 from 7,373,745 in 2023, impacting earnings per share[28] - The company completed its initial public offering of 1,150,000 shares at $9.00 on October 24, 2024[15] Partnerships and Expansion - Synergy expanded partnerships with BJ's Wholesale Clubs and Publix, offering FOCUSfactor products in all 267 BJ's locations and two products in all 1,200 Publix stores[15]

WESTBROOK, Maine, March 31, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three and twelve months ended December 31, 2024. "We are pleased to report another fantastic year. We had another full year of profitability, marking our eighth consecutive profitable quarter—a testament to the continued strength of our business and the progress we achieved throughout 2024," s ...

WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the fourth quarter and full year ended December 31, 2024, on Monday, March 31, 2025, before the open of market trading. In conjunction with reporting fourth quarter and full year 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Compa ...

WESTBROOK, Maine, March 03, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it will attend the 37th Annual ROTH Conference, March 16-18, 2025, in Dana Point, California. Synergy management will be available for one-on-one investor meetings. To request a meeting, please contact your ROTH sales representative. About Synergy CHC Corp. Synergy CHC Corp. is a provider of consumer health care an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________________to___________________________ Commission File Number: 001-42374 SYNERGY CHC CORP. (Exact name of registrant as specified in its ch ...

Financial Performance - Revenue for Q3 2024 was $7.1 million, down 34% from $10.8 million in Q3 2023[5] - Net income for Q3 2024 was $0.8 million, compared to $1.3 million in Q3 2023, reflecting a decline of 38%[10] - EBITDA for Q3 2024 was $1.3 million, down 38% from $2.2 million in Q3 2023[10] - Gross profit for the nine months ended September 30, 2024, was $17,141,106, compared to $21,207,795 for the same period last year, indicating a decrease of about 19.2%[22] - Net income after tax for the nine months ended September 30, 2024, was $2,019,309, down from $3,747,444 in the previous year, reflecting a decline of approximately 46.2%[22] - Net income per share – basic for the three months ended September 30, 2023, was $0.10, compared to $0.17 in the same period last year, a decline of approximately 41.2%[22] Margins and Expenses - Gross margin decreased to 67.2%, down 476 basis points from 72.0% in the same period last year[8] - Operating expenses for the three months ended September 30, 2023, totaled $3,739,557, compared to $5,628,898 in the same period last year, a reduction of about 33.5%[22] - Total operating expenses for the nine months ended September 30, 2024, were $12,698,310, down from $14,827,851 in the same period last year, a decrease of about 14.4%[22] - Interest expense, net for the three months ended September 30, 2023, was $704,707, compared to $885,548 in the same period last year, a decrease of about 20.4%[22] Cash and Debt Management - Cash and cash equivalents as of September 30, 2024, were approximately $259.4 thousand, down from $632.5 thousand at the end of 2023[11] - The company reduced outstanding debt by $1.1 million during Q3 2024 and an additional $3.1 million post-IPO[6] - Total liabilities decreased to $37.3 million as of September 30, 2024, from $39.5 million at the end of 2023[11] - Net cash used in operating activities for the nine months ended September 30, 2024, was $(1,377,479), an improvement from $(2,737,849) in the same period last year[25] - Cash and restricted cash at the end of the period was $359,375, compared to $337,827 at the end of the same period last year, showing a slight increase of approximately 6.5%[25] Strategic Initiatives - Synergy expanded partnerships with BJ's Wholesale Clubs and Publix, increasing distribution to 267 and 1,200 locations respectively[6] - The company aims to expand its brand distribution footprint and enter new geographical markets in 2025[3] - FOCUSfactor underwent its first re-branding since 2015, impacting sales due to retailer de-inventorying[7] Related Party Transactions - Advances from related party for the nine months ended September 30, 2024, amounted to $3,395,587, significantly higher than $1,000,000 in the previous year[25]

Financial Performance - For the three months ended March 31, 2020, the company reported revenue of $6,117,286, a decrease of 33% from $9,468,955 in the same period in 2019[150] - Gross profit for the same period was $4,619,507, representing a gross margin of 76%, compared to a gross profit of $6,928,505 and a margin of 73% in 2019[152] - Adjusted EBITDA for the three months ended March 31, 2020, was $847,193, reflecting the company's focus on evaluating operating performance[148] - The company experienced a net income of $262,303 for the three months ended March 31, 2020, down from $1,467,287 in the same period in 2019[157] - The company reported a decrease in operating expenses, with selling and marketing expenses at $2,253,956 compared to $3,311,867 in 2019[153] - The company had net cash used in operating activities of $(1,302,062) for the three months ended March 31, 2020, compared to net cash provided of $813,711 in 2019[163] Financial Position - The company's working capital deficit was $4,444,249 as of March 31, 2020, which includes loans payable to related parties of $5,486,377[166] - The company had cash on hand of $314,933 and restricted cash of $100,000 as of March 31, 2020[159] Future Plans and Strategies - The company plans to raise additional capital through a line of credit and/or loans for future mergers and acquisitions, which may be impacted by COVID-19[166] - The company intends to expand its online presence and develop new marketing campaigns for organic growth within its current product lines[171] Impact of COVID-19 - The COVID-19 pandemic has significantly impacted global economic activity, potentially disrupting the Company's operations and financial condition[172] - The Company may implement temporary precautionary measures, such as remote work for employees, which could negatively affect business operations[172] Other Considerations - The effect of inflation on the Company's operating results was not significant[176] - The preparation of financial statements requires management to make estimates and assumptions that affect reported amounts of assets, liabilities, revenue, and expenses[177] - The Company is classified as a "smaller reporting company" and is not required to provide certain market risk disclosures[179]

Revenue Composition - FOCUSfactor represents 64% of the company's revenue, while the Flat Tummy brand accounts for 32%[15][16]. - The company relies heavily on Costco and Walmart, which together comprise 78% of net revenue from retail sales[23]. Sales Strategy - The company plans to diversify its sales network and expand online sales channels to enhance market penetration[19][27]. Research and Development - The company outsources research and development to manufacturers experienced in product development[20]. - FOCUSfactor is the only product in its category with both a patent and clinical study supporting its claims[29]. - The company has a patent (U.S. Patent 8,329,227) for FOCUSfactor's formulation, which enhances mental function[25]. Workforce and Growth - The company had 36 full-time employees as of April 2020 and plans to grow its workforce in response to business demands[34]. - The company intends to continue developing product extensions and expanding into new markets[14]. Risk Factors - The COVID-19 pandemic poses risks that could disrupt business operations and impact financial conditions[35]. - The company is focused on compliance with applicable laws and regulations, which may impact future operations[30][33].

U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Synergy CHC Corp. (State or other jurisdiction (Commission (IRS Employer Nevada 000-55098 99-0379440 of Incorporation) File Number) Identification Number) ...